Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12102663 Treatment of post-bariatric hypoglycemia with exendin (9-39)

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
February 22, 2023
0
Date of Patent
October 1, 2024
0
Patent Application Number
18172546
0
Patent Citations
‌
US Patent 7297761 Pharmaceutical compositions containing exendins
0
‌
US Patent 8969293 Therapeutic agent preparations comprising exenatide for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
0
‌
US Patent 9616108 Methods and compositions for treating hypoglycemic disorders
0
‌
US Patent 9821031 Methods and compositions for treating hypoglycemic disorders
0
‌
US Patent 10188702 Methods and compositions for treating hypoglycemic disorders
0
‌
US Patent 10639354 Treatment of hyperinsulinemic hypoglycemia with exendin (9-39)
0
‌
US Patent 10653753 Treatment of hyperinsulinemic hypoglycemia with exendin-4 derivatives
0
‌
US Patent 10660937 Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39)
0
‌
US Patent 10987407 Methods and compositions for treating hypoglycemic disorders
0
‌
US Patent 10993991 Treatment of post-bariatric hypoglycemia with exendin (9-39)
0
•••
Patent Inventor Names
Tracey L. McLaughlin
0
Colleen M. Craig
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12102663
0
Patent Primary Examiner
‌
Julie Ha
0
CPC Code
‌
A61K 9/08
0
‌
A61K 9/10
0
‌
A61K 38/17
0
‌
A61K 38/22
0
‌
A61K 38/26
0
‌
A61K 45/06
0
‌
A61P 3/08
0
‌
A61K 38/2278
0
‌
A61K 9/0019
0

Find more entities like US Patent 12102663 Treatment of post-bariatric hypoglycemia with exendin (9-39)

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.